Literature DB >> 31329870

Determinants of non-participation in colon examination following positive stool sample in colorectal cancer screening.

Ulrik Deding1, Anna Sharon Henig1, Peter Hindersson2, Christian Torp-Pedersen1,3, Henrik Bøggild1,3.   

Abstract

BACKGROUND: Social inequalities has been shown for participation in colorectal cancer screening and recently in the initial stool sample blood test. If these differences persist at follow-up colon examination after a positive stool test, it would suggest that social inequality in screening may be greater than the inequality observed in initial stool sample blood test.
METHODS: All data were derived from national registers. Using logistic regression analyses, odds of non-participation for follow-up colon examination were estimated based on age group, educational level, income quartile, immigration status and marital status in men and in women, who had participated in initial stool sample test for blood with a positive result.
RESULTS: Among 20 849 men and 16 565 women invited for follow-up colonoscopy in the period 2014-15, 10.63 and 11.37%, respectively, did not attend. In men, odds of non-participation were higher in the eldest, those with lower income and lower educational level, in immigrants and in singles. Odds ratio (OR) in males of highest income quartile was 0.54 [95% confidence interval (CI) 0.46; 0.63] compared with lowest income quartile. In women, the differences were not as large. OR in females of highest income quartile was 0.73 (95% CI 0.61; 0.87) compared with lowest income quartile.
CONCLUSION: Sociodemographic differences in odds of non-participation exist in follow-up colon examination in the Danish colorectal cancer screening. Differences were evident in all subgroups of the male population. The same patterns were seen in women. Social inequalities in participation for follow-up colon examination can increase overall social inequality and consequently, lead to health disparities.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Year:  2019        PMID: 31329870     DOI: 10.1093/eurpub/ckz072

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  6 in total

1.  Harms and Benefits of Cancer Screening.

Authors:  Bernt-Peter Robra
Journal:  Recent Results Cancer Res       Date:  2021

2.  Colon capsule endoscopy in colorectal cancer screening: a randomised controlled trial.

Authors:  Lasse Kaalby; Ulrik Deding; Morten Kobaek-Larsen; Anne-Line Volden Havshoi; Erik Zimmermann-Nielsen; Marianne Kirstine Thygesen; Rasmus Kroeijer; Thomas Bjørsum-Meyer; Gunnar Baatrup
Journal:  BMJ Open Gastroenterol       Date:  2020-06

3.  Time to colonoscopy, cancer probability, and precursor lesions in the Danish colorectal cancer screening program.

Authors:  Lasse Kaalby; Morten Rasmussen; Erik Zimmermann-Nielsen; Magdalena Maria Buijs; Gunnar Baatrup
Journal:  Clin Epidemiol       Date:  2019-07-30       Impact factor: 4.790

4.  Time Trends and Income Inequalities in Cancer Incidence and Cancer-Free Life Expectancy - a Cancer Site-Specific Analysis of German Health Insurance Data.

Authors:  Fabian Tetzlaff; Jens Hoebel; Jelena Epping; Siegfried Geyer; Heiko Golpon; Juliane Tetzlaff
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

5.  Factors Associated with Participation in Stool Based Colorectal Screening in Brunei Darussalam.

Authors:  Vui Heng Chong; Lydiana Kadir; Zakaria Kamis; Norhayati Kassim; Muhammad Abdul Mabood Khalil; Jackson Tan; Elvynna Leong; Sok King Ong; Chee Fui Chong
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01

6.  Odds of Incomplete Colonoscopy in Colorectal Cancer Screening Based on Socioeconomic Status.

Authors:  Birgitte Skau; Ulrik Deding; Lasse Kaalby; Gunnar Baatrup; Morten Kobaek-Larsen; Issam Al-Najami
Journal:  Diagnostics (Basel)       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.